-Blockade in Heart Failure: Selective Versus Nonselective Agents

Author： Metra M.   Nodari S.   Dei Cas L.  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.1, Iss.1, 2001-01, pp. : 3-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective aldosterone blockade with eplerenone in patients with congestive heart failure

By Salam Amar Mohammad  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 8, 2003-08 ,pp. : 1423-1427

Informa Healthcare

Access to resources Recommend Favorite

Calcium Sensitising Agents in Heart Failure

By Mathew L.   Katz S.D.  

Drugs & Aging, Vol. 12, Iss. 3, 1998-03 ,pp. : 191-204

Adis International

Access to resources Recommend Favorite

Agents targeting inflammation in heart failure

By Gullestad Lars   Kjekshus John   Damås Jan Kristian   Ueland Thor   Yndestad Arne   Aukrust Pål  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 5, 2005-05 ,pp. : 557-566

Informa Healthcare

Access to resources Recommend Favorite

Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK

By Adis International Limited  

PharmacoEconomics, Vol. 23, Iss. 7, 2005-01 ,pp. : 743-743

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Etoricoxib versus Celecoxib and Non-Selective NSAIDS in the Treatment of Ankylosing Spondylitis

By Jansen Jeroen P.  

PharmacoEconomics, Vol. 28, Iss. 4, 2010-04 ,pp. : 323-344

Adis International

Access to resources Recommend Favorite